These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 5008233)

  • 1. Suppression of growth hormone-dependent human serum sulfation factor by estrogen.
    Wiedemann E; Schwartz E
    J Clin Endocrinol Metab; 1972 Jan; 34(1):51-8. PubMed ID: 5008233
    [No Abstract]   [Full Text] [Related]  

  • 2. Estrogenic antagonism of metabolic effects of administered growth hormone.
    Schwartz E; Wiedemann E; Simon S; Schiffer M
    J Clin Endocrinol Metab; 1969 Sep; 29(9):1176-81. PubMed ID: 4309155
    [No Abstract]   [Full Text] [Related]  

  • 3. Administration of growth hormone to patients with familial dwarfism with high plasma immunoreactive growth hormone: measurement of sulfation factor, metabolic and linear growth responses.
    Laron Z; Pertzelan A; Karp M; Kowadlo-Silbergeld A; Daughaday WH
    J Clin Endocrinol Metab; 1971 Aug; 33(2):332-42. PubMed ID: 4935640
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on sulfation factor (SF) activity of human serum. Serum SF in hypopituitarism and acromegaly.
    ALMQVIST S; IKKOS D; LUFT R
    Acta Endocrinol (Copenh); 1961 Apr; 36():577-95. PubMed ID: 13682635
    [No Abstract]   [Full Text] [Related]  

  • 5. Mechanism of estrogenic action in acromegaly.
    Schwartz E; Echemendia E; Schiffer M; Panariello VA
    J Clin Invest; 1969 Feb; 48(2):260-70. PubMed ID: 5764009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of skeletal growth by sulfation factor.
    Daughaday WH
    Adv Intern Med; 1971; 17():237-63. PubMed ID: 4949905
    [No Abstract]   [Full Text] [Related]  

  • 7. Some effects of ethinyl oestradiol on calcium and phosphorus metabolism in osteoporosis.
    Young MM; Jasani C; Smith DA; Nordin BE
    Clin Sci; 1968 Jun; 34(3):411-7. PubMed ID: 5666871
    [No Abstract]   [Full Text] [Related]  

  • 8. Quantitative determination of somatomedin in human serum (35S uptake by embryonic chick cartilage).
    Schimpff RM; Donnadieu M
    Biomedicine; 1973 Apr; 19(4):142-7. PubMed ID: 4731987
    [No Abstract]   [Full Text] [Related]  

  • 9. Quantitative determination of somatomedin in human serum ( 35 S uptake by embryonic chick cartilage).
    Schimpff RM
    Biomedicine; 1973 Apr; 19(4):142-7. PubMed ID: 4715574
    [No Abstract]   [Full Text] [Related]  

  • 10. Human somatomedin, the growth hormone dependent sulfation factor, is antilipolytic.
    Underwood LE; Hintz RL; Voina SJ; Van Wyk JJ
    J Clin Endocrinol Metab; 1972 Aug; 35(2):194-8. PubMed ID: 5072353
    [No Abstract]   [Full Text] [Related]  

  • 11. Cyclic 3'5'adenosine monophosphate inhibition of sulfation factor activity.
    Rendall JL; Delcher HK; Lebovitz HE
    Biochem Biophys Res Commun; 1972 Feb; 46(3):1425-9. PubMed ID: 4334980
    [No Abstract]   [Full Text] [Related]  

  • 12. Stimulation of DNA synthesis in isolated chondrocytes by sulfation factor.
    Garland JT; Lottes ME; Kozak S; Daughaday WH
    Endocrinology; 1972 Apr; 90(4):1086-90. PubMed ID: 4334697
    [No Abstract]   [Full Text] [Related]  

  • 13. [The serum level of sulfatation factor (somatomedine) in growth retardations, cerebral gigantism and acromegaly].
    Lecornu M
    Arch Fr Pediatr; 1973; 30(6):595-608. PubMed ID: 4375947
    [No Abstract]   [Full Text] [Related]  

  • 14. Sulphation factor activity and growth rate during long-term treatment of patients with pituitary dwarfism with human growth hormone.
    Hall K; Olin P
    Acta Endocrinol (Copenh); 1972 Mar; 69(3):417-33. PubMed ID: 5067009
    [No Abstract]   [Full Text] [Related]  

  • 15. Radioreceptor assay of insulin-like peptides in human plasma: growth hormone dependence and correlation with sulfation activity by two bioassays.
    Guyda HJ; Corvol MT; Rappaport R; Posner BI
    J Clin Endocrinol Metab; 1979 May; 48(5):739-47. PubMed ID: 429519
    [No Abstract]   [Full Text] [Related]  

  • 16. Acute and chronic estrogen effects upon serum somatomedin activity, growth hormone, and prolactin in man.
    Wiedemann E; Schwartz E; Frantz AG
    J Clin Endocrinol Metab; 1976 May; 42(5):942-52. PubMed ID: 178687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidences for antiosteoporotic and selective estrogen receptor modulator activity of silymarin compared with ethinylestradiol in ovariectomized rats.
    El-Shitany NA; Hegazy S; El-Desoky K
    Phytomedicine; 2010 Feb; 17(2):116-25. PubMed ID: 19577454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain growth-promoting activity in human serum: relationship to growth hormone and somatomedin.
    Sara VR; Stuart MC; Rutherford R; Moore S; Lazarus L
    J Clin Endocrinol Metab; 1978 Nov; 47(5):1129-31. PubMed ID: 263343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pseudohypopituitary dwarfism with normal plasma growth hormone and low serum sulfation factor.
    New MI; Schwartz E; Parks GA; Landey S; Wiedemann E
    J Pediatr; 1972 Apr; 80(4):620-6. PubMed ID: 5015070
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative effect of animal prolactins and human growth hormone (HGH) in hypopituitary children.
    Blizzard RM; Drash AL; Jenkins ME; Spaulding JS; Glick A; Weldon VV; Powell GF; Raiti S
    J Clin Endocrinol Metab; 1966 Aug; 26(8):852-8. PubMed ID: 5921153
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.